Oncologic Emergencies Part 2 Flashcards
Tumor Lysis Syndrome Risk Factors
Tumor with high proliferative rate Tumor sensitive to cytotoxic therapy Large tumor masses Leukocytosis High LDH Pre-existing renal insufficiency Hematologic malignancies
LDH + Tumor Lysis
Indirect measurement of patient’s tumor burden
Tumors sensitive to cytotoxic therapy –>
Tumors that are more sensitive will have more dying and releasing of components
Highest Risk of TLS
Burkitt’s lymphoma
Lymphoblastic lymphoma
ALL
AML
Moderate Risk of TLS
Multiple myeloma
Breast cancer
Small cell lung
Germ cell
What is Tumor Lysis Syndrome
Rapid lysis of tumor cells leads to release of intracellular content which leads to exceeding ability for normal compensatory mechanisms
Findings with TLS
Hyperuricemia
Hyperkalemia
Hyperphosphatemia
Hypocalcemia
Consequence of TLS
Renal failure
Hyperkalemia leads to
Cardiac and neuromuscular complications (cramps)
Hyperphosphotemia leads to
GI symptoms, lethargy and seizures
Hypocalcemia
Leads to cardiac arrhythmia, hypotension, tetany
Hydration + TLS
- Initiate 24-48 hours prior to therapy
- Continue until 48-72 hours after therapy
- Diuretics should be considered to have equal fluid intake and output
Alkalinize Urine + TLS
• Sodium bicarbonate or acetazolamide (inhibiters carbonic anhydrase → increases pH → increase solubility of uric acid)
GENERALLY NOT RECOMMENDED
Allopurinol MOA and Dose
Inhibits xanthine oxidase so it inhibits the formation of uric acid
Dose: LD of 600 mg and then 300 mg/day
Rasburicase MOA and Use
- Urate acid is converted to Allatoin via urate oxidase and is 5-10X more soluble than urate acid so it will get cleared quicker
- This prevents hyperuricemia and TLS
Rasburicase Dose, CI, AE
Dose: 6 mg once daily
CI: G6PD deficiency
AE: urticaria, fever, N/V
High Risk Treatment of TLS
Hydration and rasburicase
Intermediate Risk Treatment of TLS
Hydration, allopurinol
Low Risk Treatment of TLS
Clinical judgement and monitoring
Close monitoring and imagining for TLS
- CBC
- Electrolytes
- Renal function
- Urine analysis to monitor pH (not necessary)
- Fluid intake and output (make sure good flow to kidneys, so all the electrolytes and enzymes are removed quickly
Superior Vena Cave Syndrome Leads to
Increased venous pressure Airway obstruction Cerebral edema Decreased cardiac filling Decreased cardiac output
Signs and SYmptoms of SVC
Dyspnea, tachypnea Cough Venous distension Facial or arm edema Chest pain (upper part- head should and upper chest) Dysphagia Sensation of fullness in head Cyanosis
Causes of SVC
Lung cancers – SCLC
Lymphomas – NHL and HD
Head and neck cancers
Diagnosis of SVC
Chest X-ray
CT scan: neck and chest
Venography: if thrombus expected
Biopsy of mass (confirm that it is cancer)
Treatment of SVC
Goal: relieve symptoms and prevent complications
Chemotherapy or radiation (most common first line and them chemo)
Supportive Measures for SVC
Bed rest Oxygen Corticosteroid Diuretics Low salt diet
Spinal Cord Compression Presentation
Hematologic that have metastasized to the bone to lead to compression of the spinal cord
Signs and Symptoms of PCC
Pain >90% of patients Neurologic symptoms • Motor: weakness, spasticity • Sensory: numbness, ataxia • Autonomic dysfunction (loss of control of bowel movements) • Paraplegia
Diagnosis of PCC
X-ray of spine
MRI/CT of spine
Treatment of PCC
Dexamethasone to reduce edema
Radiation (treatment of choice)